Provention Bio Inc (PRVB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PRVB Annual Balance Sheets →
Quarterly balance sheet trends provide context on Provention Bio Inc's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent44.04
Marketable Securities, Current SH120.96
Cash & Short-term Investments164.00
Accounts receivable1.36
Inventories1.23
Other Current Assets0.00
Prepaid Expense And Other Assets Current7.06
Total Current Assets174.65
Equipment/Property/Plant Net2.21
Intangible Assets59.56
Long-term investments0.00
Other Assets, Noncurrent0.44
Operating Lease Right Of Use Asset0.32
Total Assets236.86
Liabilities
Accounts Payable, Current AC6.76
Accrued Liabilities, Current AC20.76
Other Liabilities, Current62.87
Total Current Liabilities90.39
Long-term debt23.47
Total Long-term Debt23.47
Other liabilities, Noncurrent1.15
OperatingLeaseLiabilityNoncurrent0.44
Contract With Customer Liability Current17.69
Total Liabilities115.01
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock528.13
Retained Earnings / Accumulated Deficit-405.64
Other Equity-0.65
Common Stockholder's Equity121.85
Total Stockholder's Equity121.85
Liabilities & Stockholder's Equity236.86
4 historic quarters locked

Sign in to unlock the full Provention Bio Inc balance sheet history.

About Provention Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-23-009516

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.